Company Filing History:
2 out of 60 
1 out of 3,539 
1 out of 3 Years Active: 2022-2025
Title: The Innovations of George Ettenger
Introduction
George Ettenger is a notable inventor based in Missoula, MT (US), recognized for his contributions to the field of biochemistry and pharmaceuticals. With a total of four patents to his name, Ettenger has made significant strides in developing compounds that have potential applications in medical treatments.
Latest Patents
Ettenger's latest patents include innovative compounds such as diaryl trehalose compounds and methods of use thereof. These compounds are particularly noteworthy for their potential as vaccine adjuvants. Another significant patent involves toll-like receptor ligands that feature an allose-based core. These ligands are stable in aqueous formulations and are useful in treating, preventing, or reducing susceptibility to various diseases mediated by toll-like receptors, including cancer, infectious diseases, allergies, autoimmune diseases, sepsis, and ischemia reperfusion.
Career Highlights
Throughout his career, George Ettenger has worked with esteemed institutions such as the University of Montana and the National Institutes of Health, a component of the US Department of Health & Human Services. His work in these organizations has allowed him to contribute to important research and development in the field of health sciences.
Collaborations
Ettenger has collaborated with notable colleagues, including Kendal T. Ryter and David Burkhart. These partnerships have facilitated the advancement of his research and the successful development of his patented innovations.
Conclusion
George Ettenger's work exemplifies the impact of innovative thinking in the field of biochemistry. His patents and collaborations highlight his commitment to advancing medical science and improving health outcomes.